Clinical Trial Update: Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on allogeneic bone marrow-derived mesenchymal stromal cell therapy for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Allogeneic bone marrow mesenchymal stromal cell therapy

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Knee Osteoarthritis | Phase 1, Phase 2 | Status: COMPLETED